Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletions in a large clinical cohort
Clicks: 255
ID: 266169
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
255 views
42 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #7 of 9 articles by views in Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This is a large-scale prospective clinical evaluation of the sensitivity and specificity of a targeted cfDNA test for fetal 22q11.2 deletions. Results demonstrate that this targeted cfDNA test can detect common and smaller, nested 22q11.2 deletions with a low (0-0.5%) false positive rate. Although t …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (45 words).
Try re-searching for a better abstract.
| Reference Key |
e2021ultrasoundperformance
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bevilacqua E;Jani J;Chaoui R;Suk EA;Palma-Dias R;Ko TM;Warsof S;Stokowski R;Jones KJ;Grati FR;Schmid M;; |
| Journal | Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology |
| Year | 2021 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.